Arkolith/Insider Trading/CLDX/Form 4

Martin Samuel Bates

SVP AND CFOCelldex Therapeutics, Inc. (CLDX) · full profile →Form 4 · filed Jun 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$608K
Net Open-Market Flow
-$608K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 14, 2024Sell(S)17K$35.42$608K28K
Jun 14, 2024Option exercise(M)17K$10.38$176K45K
Jun 14, 2024Option exercise(M)3K$9.02$29K28K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 14, 2024Option exercise(M)3K—$00
Jun 14, 2024Option exercise(M)17K—$064K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-017363) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML